Vedolizumab for Inflammatory Bowel Disease: two year results of the ICC Registry, a nationwide prospective observational cohort study
Latest Information Update: 09 Nov 2019
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
Most Recent Events
- 09 Nov 2019 New trial record
- 02 Nov 2019 Results published in the Clinical Pharmacology and Therapeutics